Patent US5677451A successfully refreshed from Google Patents.
US5677451A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
Assignee: Allergan Inc
•
Filing: 1995-06-06
•
Granted: 1997-10-14
•
Expires: 2015-06-06
Abstract
Abstract Compounds of the formula ##STR1## where R 1 and R 2 , independently are alkyl groups having 2 to 8 carbons; R 3 is hydrogen or lower alkyl; X is S, O or N-R 4 where R 4 is hydrogen or lower alkyl; Y is phenyl or pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl, and pyrazinyl; A is (CH 2 ) n where n is 0-5, or lower branched chain alkyl, alkenyl having 2 to 6 carbons and 1 or 2 double bonds, alkynyl having 2 to 6 carbons and 1 or 2 triple bonds; B is hydrogen, COOH or a salt thereof, COOR 5 , CONR 6 R 7 , --CH 2 OH, CH.sub. 2OR 8 , CH 2 OCOR 8 , CHO, CH(OR 9 ) 2 , CHOR 10 O, --COR 11 , CR 11 (OR 9 ) 2 , or CR11OR 10 O, where R 5 is alkyl of 1 to 10 carbons, or cycloalkyl of 5 to 10 carbons, or R 5 is phenyl or lower alkylphenyl, R 6 and R 7 independently are hydrogen, alkyl of 1 to 10 carbons, or cycloalkyl of 5 to 10 carbons, or phenyl or lower alkylphenyl, R 8 is alkyl of 1 to 10 carbons, phenyl or lower alkylphenyl, R 9 is lower alkyl, R 10 is divalent alkyl radical of 2-5 carbons and R 11 is alkyl, cycloalkyl or alkenyl containing 1 to 5 carbons, have retinoic acid like activity.
Inventors
- 👤 Roshantha A. S. Chandraratna
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 20:22
CPC Classifications
C; C07; C07D; C07D335/00; C07D335/04; C07D335/06; A; A61; A61P; A61P13/00; A61P13/02; A61P15/00; A61P17/00; A61P27/00; A61P27/02; A61P29/00; A61P35/00; A61P37/00; A61P37/02; A61P37/06; A61P9/00; A61P9/10; C07D215/00; C07D215/02; C07D215/12; C07D311/00; C07D311/02; C07D311/04; C07D311/58; C07D401/00; C07D401/02; C07D401/06; C07D405/00; C07D405/02; C07D405/06; C07D407/00; C07D407/02; C07D407/06; C07D409/00; C07D409/02; C07D409/06
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
281 words
A compound of the formula ##STR11## wherein R 1 and R 2 , independently are n-alkyl groups having 2 to 8 carbons, or cyclo or branch-chained alkyl groups of 3 to 8 carbons; R 3 is hydrogen or lower alkyl; X is S, O or N-R 4 where R 4 is hydrogen or lower alkyl; Y is phenyl or a heteroaryl group selected from a group consisting of pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl, and pyrazinyl; A is (CH 2 ) n where n is 0-5, lower branched chain alkyl having 3 to 6 carbons, cycloalkyl having 3 to 6 carbons, alkenyl having 2 to 6 carbons and I or 2 double bonds, alkynyl having 2 to 6 carbons and 1 or 2 triple bonds; B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 5 , CONR 6 R 7 , --CH 2 OH, CH 2 OR 8 , CH 2 OCOR 8 , CHO, CH(OR 9 ) 2 , CHOR 10 O, --COR 11 , CR 11 (OR 9 ) 2 , or CR 11 OR 10 O, where R 5 is an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 5 is phenyl or lower alkylphenyl, R 6 and R 7 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or phenyl or lower alkylphenyl, R 8 is alkyl of 1 to 10 carbons, phenyl or lower alkylphenyl, R 9 is lower alkyl, R 10 is divalent alkyl radical of 2-5 carbons and R 11 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons.
Claim 2
Dependent Claim
281 words
A compound of the formula ##STR11## wherein R 1 and R 2 , independently are n-alkyl groups having 2 to 8 carbons, or cyclo or branch-chained alkyl groups of 3 to 8 carbons; R 3 is hydrogen or lower alkyl; X is S, O or N-R 4 where R 4 is hydrogen or lower alkyl; Y is phenyl or a heteroaryl group selected from a group consisting of pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl, and pyrazinyl; A is (CH 2 ) n where n is 0-5, lower branched chain alkyl having 3 to 6 carbons, cycloalkyl having 3 to 6 carbons, alkenyl having 2 to 6 carbons and I or 2 double bonds, alkynyl having 2 to 6 carbons and 1 or 2 triple bonds; B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 5 , CONR 6 R 7 , --CH 2 OH, CH 2 OR 8 , CH 2 OCOR 8 , CHO, CH(OR 9 ) 2 , CHOR 10 O, --COR 11 , CR 11 (OR 9 ) 2 , or CR 11 OR 10 O, where R 5 is an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 5 is phenyl or lower alkylphenyl, R 6 and R 7 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or phenyl or lower alkylphenyl, R 8 is alkyl of 1 to 10 carbons, phenyl or lower alkylphenyl, R 9 is lower alkyl, R 10 is divalent alkyl radical of 2-5 carbons and R 11 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons.
Claim 3
Dependent Claim
11 words
A compound in accordance with claim 1 where X is NH.
Claim 4
Dependent Claim
21 words
A compound in accordance with claim 1 where X the R 1 and R 2 groups are identical with one another.
Claim 5
Dependent Claim
18 words
A compound in accordance with claim 1 where the R 1 and R 2 groups are both n-alkyl.
Claim 6
Dependent Claim
19 words
A compound in accordance with claim 1 where Y is selected from a group consisting of pyridyl,! thienyl, furyl.
Claim 7
Dependent Claim
19 words
A compound in accordance with claim 5 where Y is selected from a group consisting of pyridyl and thienyl.
Claim 8
Dependent Claim
201 words
A compound of the formula ##STR12## where R 1 and R 2 , independently are n-alkyl groups having 2 to 8 carbons; R 3 is hydrogen or lower alkyl; Z is S or O; A is (CH 2 ) n where n is 0-5, and B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 5 , CONR 6 R 7 , --CH 2 OH, CH 2 OR 8 , CH 2 OCOR 8 , CHO, CH(OR 9 ) 2 , CHOR 10 O, --COR 11 , CR 11 (OR 9 ) 2 , or CR 11 OR 10 O, where R 5 is an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 5 is phenyl or lower alkylphenyl, R 6 and R 7 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or phenyl or lower alkylphenyl, R 8 is alkyl of 1 to 10 carbons, phenyl or lower alkylphenyl, R 9 is lower alkyl, R10 is divalent alkyl radical of 2-5 carbons and R 11 is an alkyl, cycloalkyl or alkenyl group containing i to 5 carbons.
Claim 9
Dependent Claim
201 words
A compound of the formula ##STR12## where R 1 and R 2 , independently are n-alkyl groups having 2 to 8 carbons; R 3 is hydrogen or lower alkyl; Z is S or O; A is (CH 2 ) n where n is 0-5, and B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 5 , CONR 6 R 7 , --CH 2 OH, CH 2 OR 8 , CH 2 OCOR 8 , CHO, CH(OR 9 ) 2 , CHOR 10 O, --COR 11 , CR 11 (OR 9 ) 2 , or CR 11 OR 10 O, where R 5 is an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 5 is phenyl or lower alkylphenyl, R 6 and R 7 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or phenyl or lower alkylphenyl, R 8 is alkyl of 1 to 10 carbons, phenyl or lower alkylphenyl, R 9 is lower alkyl, R10 is divalent alkyl radical of 2-5 carbons and R 11 is an alkyl, cycloalkyl or alkenyl group containing i to 5 carbons.
Claim 10
Dependent Claim
19 words
A compound in accordance with claim 7 where A is (CH 2 ) n and where n is 0.
Claim 11
Dependent Claim
24 words
A compound in accordance with claim 8 where B is COOH, COOR 5 , CONR 6 R 7 or a pharmaceutically. acceptable salt thereof.
References Cited (Backward Citations)
US4096341A
Cited
US4326055A
Cited
US4391731A
Cited
DE3316932A1
Cited
EP0098591A1
Cited
EP0130795A2
Cited
WO1985000806A1
Cited
WO1985004652A1
Cited
US4826984A
Cited
US4695649A
Cited
DE3524199A1
Cited
EP0170105A2
Cited
US4723028A
Cited
US4740519A
Cited
EP0176033A2
Cited
EP0176034A2
Cited
EP0176032A2
Cited
US4826969A
Cited
DE3602473A1
Cited
DE3708060A1
Cited
US4855320A
Cited
GB2190378A
Cited
DE3715955A1
Cited
EP0253302A2
Cited
US4739098A
Cited
EP0272921A1
Cited
US4927947A
Cited
US5264578A
Cited
EP0284288A1
Cited
US5380877A
Cited
US5234926A
Cited
US5354752A
Cited
US5348972A
Cited
US4810804A
Cited
EP0303915A2
Cited
EP0315071A2
Cited
US5231113A
Cited
US5130335A
Cited
US4895868A
Cited
US5015658A
Cited
US5037825A
Cited
EP0350846A2
Cited
US5089509A
Cited
US4992468A
Cited
US5068252A
Cited
US4980369A
Cited
US5045551A
Cited
US5272156A
Cited
US5162546A
Cited
US5053523A
Cited
US5183827A
Cited
US5399561A
Cited
US5023341A
Cited
US5407937A
Cited
US5248777A
Cited
US5278318A
Cited
US5414007A
Cited
US5264456A
Cited
US5006550A
Cited
US5013744A
Cited
US5175185A
Cited
US5013744B1
Cited
US5202471A
Cited
US5349105A
Cited
WO1991016051A1
Cited
WO1992006948A1
Cited
US5346915A
Cited
US5348975A
Cited
US5346895A
Cited
US5324744A
Cited
US5134159A
Cited
US5326898A
Cited
US5391753A
Cited
US5434173A
Cited
US5324840A
Cited
US5399586A
Cited
US5344959A
Cited
US5426118A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-10-13 | 2001-04-14 | 2001-10-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-10-13 | 2005-04-14 | 2005-10-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-10-13 | 2009-04-14 | 2009-10-14 | $7700.00 | Window Closed / Lapsed |